AI Verdict
AMZN has stronger fundamentals based on our AI analysis.
NTLA vs AMZN Fundamental Comparison
| Metric | NTLA | AMZN |
|---|---|---|
| Revenue | $67.7M | $716.9B |
| Net Income | $-412.7M | $77.7B |
| Net Margin | -609.9% | 10.8% |
| ROE | -61.5% | 18.9% |
| ROA | -49.0% | 9.5% |
| Current Ratio | 5.08x | 1.05x |
| Debt/Equity | 0.00x | 0.17x |
| EPS | $-3.81 | $7.17 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NTLA vs AMZN: Frequently Asked Questions
Is NTLA or AMZN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), AMZN has stronger fundamentals. NTLA is rated SELL (92% confidence) while AMZN is rated BUY (81% confidence). This is not investment advice.
How does NTLA compare to AMZN fundamentally?
Intellia Therapeutics, Inc. has ROE of -61.5% vs AMAZON COM INC's 18.9%. Net margins are -609.9% vs 10.8% respectively.
Which stock pays higher dividends, NTLA or AMZN?
NTLA has a dividend yield of N/A or no dividend while AMZN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NTLA or AMZN for long term?
For long-term investing, consider that NTLA has SELL rating with 92% confidence, while AMZN has BUY rating with 81% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NTLA vs AMZN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NTLA vs AMZN, the AI consensus favors AMZN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.